Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
22
KROS
Keros Therapeutics
Last Price:
54.22
Seasonality Move:
-16.78%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.46 | Sell |
20-day SMA: | 60.92 | Sell |
50-day SMA: | 63.51 | Sell |
200-day SMA: | 44.18 | Buy |
8-day EMA: | 57.57 | Sell |
20-day EMA: | 60.06 | Sell |
50-day EMA: | 60.21 | Sell |
200-day EMA: | 49.71 | Buy |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.1 | Sell |
Relative Strength Index (14 RSI): | 37.31 | Sell |
Chaikin Money Flow: | -34931 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.2 - 66) | Sell |
Bollinger Bands (100): | (42.32 - 66.2) | Buy |
Keros Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 56.24 while KROS 8-day simple moving average is 57.46, which is a Sell signal.
- The stock price of KROS is 56.24 while Keros Therapeutics 20-day SMA is 60.92, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 63.51 while KROS share price is 56.24, making it a Sell technically.
- KROS stock price is 56.24 and Keros Therapeutics 200-day simple moving average is 44.18, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
22
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $56.24. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.02B
Price in USD:
56.24
Share Volume:
256.7K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
22
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 56.24 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 56.24 while KROS 8-day exponential moving average is 57.57, which is a Sell signal.
- The stock price of KROS is 56.24 while Keros Therapeutics 20-day EMA is 60.06, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 60.21 while KROS share price is 56.24, making it a Sell technically.
- KROS stock price is 56.24 and Keros Therapeutics 200-day simple moving average is 49.71, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -2.1, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 37.31, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (58.2 - 66), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (42.32 - 66.2), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.